{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:43:17Z","timestamp":1790203397131,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Molecular chaperones assist proteins in achieving a functional structure and prevent them from misfolding into aggregates, including disease-associated deposits. The BRICHOS domain from familial dementia associated protein Bri2 (or ITM2B) probably chaperones its specific proprotein region with high \u03b2-sheet propensity during biosynthesis. Recently, Bri2 BRICHOS activity was found to extend to other amyloidogenic, fibril forming peptides, in particular, Alzheimer\u2019s disease associated amyloid-\u03b2 peptide, as well as to amorphous aggregate forming proteins. However, the biological functions of the central nervous system specific homologue Bri3 BRICHOS are still to be elucidated. Here we give a detailed characterisation of the recombinant human (rh) Bri3 BRICHOS domain and compare its structural and functional properties with rh Bri2 BRICHOS. The results show that rh Bri3 BRICHOS forms more and larger oligomers, somewhat more efficiently prevents non-fibrillar protein aggregation, and less efficiently reduces A\u03b242 fibril formation compared to rh Bri2 BRICHOS. This suggests that Bri2 and Bri3 BRICHOS have overlapping molecular mechanisms and that their apparently different tissue expression and processing may result in different physiological functions.<\/jats:p>","DOI":"10.1038\/s41598-020-66718-y","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T10:05:07Z","timestamp":1592388307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Recombinant Bri3 BRICHOS domain is a molecular chaperone with effect against amyloid formation and non-fibrillar protein aggregation"],"prefix":"10.1038","volume":"10","author":[{"given":"Helen","family":"Poska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Tigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Kaldm\u00e4e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet E","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gefei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"66718_CR1","doi-asserted-by":"publisher","first-page":"aac4354","DOI":"10.1126\/science.aac4354","volume":"353","author":"D Balchin","year":"2016","unstructured":"Balchin, D., Hayer-Hartl, M. & Hartl, F. U. In vivo aspects of protein folding and quality control. Science 353, aac4354, https:\/\/doi.org\/10.1126\/science.aac4354 (2016).","journal-title":"Science"},{"key":"66718_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature10317","volume":"475","author":"FU Hartl","year":"2011","unstructured":"Hartl, F. U., Bracher, A. & Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 475, 324\u2013332, https:\/\/doi.org\/10.1038\/nature10317 (2011).","journal-title":"Nature"},{"key":"66718_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0065-3233(08)60320-4","volume":"50","author":"M Sunde","year":"1997","unstructured":"Sunde, M. & Blake, C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50, 123\u2013159 (1997).","journal-title":"Adv. Protein Chem."},{"key":"66718_CR4","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1073\/pnas.0915166107","volume":"107","author":"L Goldschmidt","year":"2010","unstructured":"Goldschmidt, L., Teng, P. K., Riek, R. & Eisenberg, D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA 107, 3487\u20133492, https:\/\/doi.org\/10.1073\/pnas.0915166107 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"66718_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/35065514","volume":"410","author":"M F\u00e4ndrich","year":"2001","unstructured":"F\u00e4ndrich, M., Fletcher, M. A. & Dobson, C. M. Amyloid fibrils from muscle myoglobin. Nature 410, 165\u2013166, https:\/\/doi.org\/10.1038\/35065514 (2001).","journal-title":"Nature"},{"key":"66718_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","volume":"25","author":"MD Benson","year":"2018","unstructured":"Benson, M. D. et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 25, 215\u2013219, https:\/\/doi.org\/10.1080\/13506129.2018.1549825 (2018).","journal-title":"Amyloid"},{"key":"66718_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356, https:\/\/doi.org\/10.1126\/science.1072994 (2002).","journal-title":"Science"},{"key":"66718_CR8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard, C. et al. Alzheimer\u2019s disease. Lancet 377, 1019\u20131031, https:\/\/doi.org\/10.1016\/S0140-6736(10)61349-9 (2011).","journal-title":"Lancet"},{"key":"66718_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D. M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535\u2013539, https:\/\/doi.org\/10.1038\/416535a (2002).","journal-title":"Nature"},{"key":"66718_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101\u2013112, https:\/\/doi.org\/10.1038\/nrm2101 (2007).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"66718_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0968-0004(02)02134-5","volume":"27","author":"L Sanchez-Pulido","year":"2002","unstructured":"Sanchez-Pulido, L., Devos, D. & Valencia, A. BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem. Sci. 27, 329\u2013332 (2002).","journal-title":"Trends Biochem. Sci."},{"key":"66718_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-2-180","volume":"2","author":"J Hedlund","year":"2009","unstructured":"Hedlund, J., Johansson, J. & Persson, B. BRICHOS - a superfamily of multidomain proteins with diverse functions. BMC Res Notes 2, 180, https:\/\/doi.org\/10.1186\/1756-0500-2-180 (2009).","journal-title":"BMC Res Notes"},{"key":"66718_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jmb.2009.04.021","volume":"389","author":"H Johansson","year":"2009","unstructured":"Johansson, H., Nerelius, C., Nordling, K. & Johansson, J. Preventing amyloid formation by catching unfolded transmembrane segments. J. Mol. Biol. 389, 227\u2013229, https:\/\/doi.org\/10.1016\/j.jmb.2009.04.021 (2009).","journal-title":"J. Mol. Biol."},{"key":"66718_CR14","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1021\/bi400908x","volume":"52","author":"SD Knight","year":"2013","unstructured":"Knight, S. D., Presto, J., Linse, S. & Johansson, J. The BRICHOS domain, amyloid fibril formation, and their relationship. Biochemistry 52, 7523\u20137531, https:\/\/doi.org\/10.1021\/bi400908x (2013).","journal-title":"Biochemistry"},{"key":"66718_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fnins.2017.00119","volume":"11","author":"JN Buxbaum","year":"2017","unstructured":"Buxbaum, J. N. & Johansson, J. Transthyretin and BRICHOS: The Paradox of Amyloidogenic Proteins with Anti-Amyloidogenic Activity for Abeta in the Central Nervous System. Front Neurosci 11, 119, https:\/\/doi.org\/10.3389\/fnins.2017.00119 (2017).","journal-title":"Front Neurosci"},{"key":"66718_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BJ20080981","volume":"416","author":"C Nerelius","year":"2008","unstructured":"Nerelius, C. et al. Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein C. Biochem. J. 416, 201\u2013209, https:\/\/doi.org\/10.1042\/BJ20080981 (2008).","journal-title":"Biochem. J."},{"key":"66718_CR17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/21637","volume":"399","author":"R Vidal","year":"1999","unstructured":"Vidal, R. et al. A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 399, 776\u2013781, https:\/\/doi.org\/10.1038\/21637 (1999).","journal-title":"Nature"},{"key":"66718_CR18","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1073\/pnas.080076097","volume":"97","author":"R Vidal","year":"2000","unstructured":"Vidal, R. et al. A decamer duplication in the 3\u2019 region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci USA 97, 4920\u20134925, https:\/\/doi.org\/10.1073\/pnas.080076097 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"66718_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbrc.2009.12.122","volume":"393","author":"S Peng","year":"2010","unstructured":"Peng, S., Fitzen, M., Jornvall, H. & Johansson, J. The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation. Biochem. Biophys. Res. Commun. 393, 356\u2013361, https:\/\/doi.org\/10.1016\/j.bbrc.2009.12.122 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"66718_CR20","doi-asserted-by":"publisher","first-page":"31608","DOI":"10.1074\/jbc.M112.393157","volume":"287","author":"H Willander","year":"2012","unstructured":"Willander, H. et al. BRICHOS domains efficiently delay fibrillation of amyloid beta-peptide. J. Biol. Chem. 287, 31608\u201331617, https:\/\/doi.org\/10.1074\/jbc.M112.393157 (2012).","journal-title":"J. Biol. Chem."},{"key":"66718_CR21","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1042\/BCJ20160277","volume":"473","author":"H Poska","year":"2016","unstructured":"Poska, H. et al. Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Abeta42 toxicity in Drosophila. Biochem. J. 473, 3683\u20133704, https:\/\/doi.org\/10.1042\/BCJ20160277 (2016).","journal-title":"Biochem. J."},{"key":"66718_CR22","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.1523\/JNEUROSCI.1195-14.2014","volume":"34","author":"FR Kurudenkandy","year":"2014","unstructured":"Kurudenkandy, F. R. et al. Amyloid-beta-induced action potential desynchronization and degradation of hippocampal gamma oscillations is prevented by interference with peptide conformation change and aggregation. J. Neurosci. 34, 11416\u201311425, https:\/\/doi.org\/10.1523\/JNEUROSCI.1195-14.2014 (2014).","journal-title":"J. Neurosci."},{"key":"66718_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nsmb.2971","volume":"22","author":"SI Cohen","year":"2015","unstructured":"Cohen, S. I. et al. A molecular chaperone breaks the catalytic cycle that generates toxic Abeta oligomers. Nat Struct Mol Biol 22, 207\u2013213, https:\/\/doi.org\/10.1038\/nsmb.2971 (2015).","journal-title":"Nat Struct Mol Biol"},{"key":"66718_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1242\/dmm.014787","volume":"7","author":"E Hermansson","year":"2014","unstructured":"Hermansson, E. et al. The chaperone domain BRICHOS prevents CNS toxicity of amyloid-beta peptide in Drosophila melanogaster. Dis Model Mech 7, 659\u2013665, https:\/\/doi.org\/10.1242\/dmm.014787 (2014).","journal-title":"Dis Model Mech"},{"key":"66718_CR25","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1021\/bi900135c","volume":"48","author":"C Nerelius","year":"2009","unstructured":"Nerelius, C., Gustafsson, M., Nordling, K., Larsson, A. & Johansson, J. Anti-amyloid activity of the C-terminal domain of proSP-C against amyloid beta-peptide and medin. Biochemistry 48, 3778\u20133786, https:\/\/doi.org\/10.1021\/bi900135c (2009).","journal-title":"Biochemistry"},{"key":"66718_CR26","doi-asserted-by":"publisher","first-page":"E2752","DOI":"10.1073\/pnas.1715951115","volume":"115","author":"ME Oskarsson","year":"2018","unstructured":"Oskarsson, M. E. et al. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells. Proc Natl Acad Sci USA 115, E2752\u2013E2761, https:\/\/doi.org\/10.1073\/pnas.1715951115 (2018).","journal-title":"Proc Natl Acad Sci USA"},{"key":"66718_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0378-1119(01)00374-2","volume":"266","author":"R Vidal","year":"2001","unstructured":"Vidal, R. et al. Sequence, genomic structure and tissue expression of Human BRI3, a member of the BRI gene family. Gene 266, 95\u2013102 (2001).","journal-title":"Gene"},{"key":"66718_CR28","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1074\/jbc.M807485200","volume":"284","author":"L Martin","year":"2009","unstructured":"Martin, L., Fluhrer, R. & Haass, C. Substrate requirements for SPPL2b-dependent regulated intramembrane proteolysis. J. Biol. Chem. 284, 5662\u20135670, https:\/\/doi.org\/10.1074\/jbc.M807485200 (2009).","journal-title":"J. Biol. Chem."},{"key":"66718_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/ADR-170051","volume":"2","author":"L Dolfe","year":"2018","unstructured":"Dolfe, L. et al. The Bri2 and Bri3 BRICHOS Domains Interact Differently with A\u03b242 and Alzheimer Amyloid Plaques. Journal of Alzheimer\u2019s Disease Reports 2, 27\u201339, https:\/\/doi.org\/10.3233\/ADR-170051 (2018).","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"key":"66718_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10948","volume":"7","author":"P Arosio","year":"2016","unstructured":"Arosio, P. et al. Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation. Nat Commun 7, 10948, https:\/\/doi.org\/10.1038\/ncomms10948 (2016).","journal-title":"Nat Commun"},{"key":"66718_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02056-4","volume":"8","author":"G Chen","year":"2017","unstructured":"Chen, G. et al. Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state. Nat Commun 8, 2081, https:\/\/doi.org\/10.1038\/s41467-017-02056-4 (2017).","journal-title":"Nat Commun"},{"key":"66718_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s42003-020-0757-z","volume":"3","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Augmentation of Bri2 molecular chaperone activity against amyloid-\u03b2 reduces neurotoxicity in mouse hippocampus in vitro. Communications Biology 3, 32, https:\/\/doi.org\/10.1038\/s42003-020-0757-z (2020).","journal-title":"Communications Biology"},{"key":"66718_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. The I-TASSER Suite: protein structure and function prediction. Nat Methods 12, 7\u20138, https:\/\/doi.org\/10.1038\/nmeth.3213 (2015).","journal-title":"Nat Methods"},{"key":"66718_CR34","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1073\/pnas.1114740109","volume":"109","author":"H Willander","year":"2012","unstructured":"Willander, H. et al. High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci USA 109, 2325\u20132329, https:\/\/doi.org\/10.1073\/pnas.1114740109 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"66718_CR35","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","volume":"25","author":"A Hawe","year":"2008","unstructured":"Hawe, A., Sutter, M. & Jiskoot, W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res. 25, 1487\u20131499, https:\/\/doi.org\/10.1007\/s11095-007-9516-9 (2008).","journal-title":"Pharm. Res."},{"key":"66718_CR36","doi-asserted-by":"publisher","first-page":"9758","DOI":"10.1073\/pnas.1218402110","volume":"110","author":"SI Cohen","year":"2013","unstructured":"Cohen, S. I. et al. Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci USA 110, 9758\u20139763, https:\/\/doi.org\/10.1073\/pnas.1218402110 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"66718_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00795-018-0191-1","volume":"52","author":"S Matsuda","year":"2019","unstructured":"Matsuda, S. & Senda, T. BRI2 as an anti-Alzheimer gene. Med Mol Morphol 52, 1\u20137, https:\/\/doi.org\/10.1007\/s00795-018-0191-1 (2019).","journal-title":"Med Mol Morphol"},{"key":"66718_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1471-4159.2004.02840.x","volume":"92","author":"L Wickham","year":"2005","unstructured":"Wickham, L., Benjannet, S., Marcinkiewicz, E., Chretien, M. & Seidah, N. G. Beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: binding partners processed by furin. J. Neurochem. 92, 93\u2013102, https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02840.x (2005).","journal-title":"J. Neurochem."},{"key":"66718_CR39","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1074\/jbc.M706661200","volume":"283","author":"L Martin","year":"2008","unstructured":"Martin, L. et al. Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a\/SPPL2b. J. Biol. Chem. 283, 1644\u20131652, https:\/\/doi.org\/10.1074\/jbc.M706661200 (2008).","journal-title":"J. Biol. Chem."},{"key":"66718_CR40","doi-asserted-by":"publisher","first-page":"28912","DOI":"10.1074\/jbc.C500217200","volume":"280","author":"S Matsuda","year":"2005","unstructured":"Matsuda, S. et al. The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. J. Biol. Chem. 280, 28912\u201328916, https:\/\/doi.org\/10.1074\/jbc.C500217200 (2005).","journal-title":"J. Biol. Chem."},{"key":"66718_CR41","doi-asserted-by":"publisher","first-page":"8668","DOI":"10.1523\/JNEUROSCI.2094-08.2008","volume":"28","author":"S Matsuda","year":"2008","unstructured":"Matsuda, S., Giliberto, L., Matsuda, Y., McGowan, E. M. & D\u2019Adamio, L. BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate. J. Neurosci. 28, 8668\u20138676, https:\/\/doi.org\/10.1523\/JNEUROSCI.2094-08.2008 (2008).","journal-title":"J. Neurosci."},{"key":"66718_CR42","doi-asserted-by":"publisher","first-page":"15815","DOI":"10.1074\/jbc.M109.006403","volume":"284","author":"S Matsuda","year":"2009","unstructured":"Matsuda, S., Matsuda, Y. & D\u2019Adamio, L. BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2. J. Biol. Chem. 284, 15815\u201315825, https:\/\/doi.org\/10.1074\/jbc.M109.006403 (2009).","journal-title":"J. Biol. Chem."},{"key":"66718_CR43","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.neurobiolaging.2009.08.005","volume":"32","author":"S Matsuda","year":"2011","unstructured":"Matsuda, S., Matsuda, Y., Snapp, E. L. & D\u2019Adamio, L. Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles. Neurobiol. Aging 32, 1400\u20131408, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.08.005 (2011).","journal-title":"Neurobiol. Aging"},{"key":"66718_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/emmm.201100195","volume":"4","author":"R Tamayev","year":"2012","unstructured":"Tamayev, R., Matsuda, S., Arancio, O. & D\u2019Adamio, L. beta- but not gamma-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. EMBO Mol Med 4, 171\u2013179, https:\/\/doi.org\/10.1002\/emmm.201100195 (2012).","journal-title":"EMBO Mol Med"},{"key":"66718_CR45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.bbapap.2015.04.005","volume":"1854","author":"H Biverstal","year":"2015","unstructured":"Biverstal, H. et al. Dissociation of a BRICHOS trimer into monomers leads to increased inhibitory effect on Abeta42 fibril formation. Biochim. Biophys. Acta 1854, 835\u2013843, https:\/\/doi.org\/10.1016\/j.bbapap.2015.04.005 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"66718_CR46","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J Comput Chem 25, 1605\u20131612, https:\/\/doi.org\/10.1002\/jcc.20084 (2004).","journal-title":"J Comput Chem"},{"key":"66718_CR47","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1111\/j.1742-4658.2008.06862.x","volume":"276","author":"DM Walsh","year":"2009","unstructured":"Walsh, D. M. et al. A facile method for expression and purification of the Alzheimer\u2019s disease-associated amyloid beta-peptide. FEBS J 276, 1266\u20131281, https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06862.x (2009).","journal-title":"FEBS J"},{"key":"66718_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-2522-3_3","volume":"1292","author":"M Haslbeck","year":"2015","unstructured":"Haslbeck, M. & Buchner, J. Assays to characterize molecular chaperone function in vitro. Methods Mol. Biol. 1292, 39\u201351, https:\/\/doi.org\/10.1007\/978-1-4939-2522-3_3 (2015).","journal-title":"Methods Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66718-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66718-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66718-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:34:54Z","timestamp":1670330094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66718-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66718"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66718-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"4 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9817"}}